{
  "id": 20595857,
  "title": "Pfizer gets into in vivo CAR-T through licensing deal with Starna Therapeutics",
  "url": "https://urgent.news/2026/11/18/pfizer-gets-into-in-vivo-car-t-through-licensing-deal-with-starna",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-18T12:23:46.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/pfizer-gets-into-in-vivo-car-t-through-licensing-deal-with-starna-therapeutics/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Pfizer is set to pay $330 million upfront to Starna Therapeutics to take exclusive rights to three pre-IND in vivo CAR-T assets in autoimmune disease outside of Greater China. Plus, the pharma will also get ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}